Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Cholera Vaccine in Children With IBD
NCT03998449Completed
- Sponsor
- Medical University of Warsaw
- Start
- Aug 2017
- Primary completion
- Apr 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of cholera vaccine (inactivated, oral) in cholera, sponsored by Medical University of Warsaw. Primary endpoint: Achieving seroprotective antibody concentration. Started Aug 2017; status: completed.
02
Drugs
cholera vaccine (inactivated, oral)
03
Conditions
cholera
Beyond the preview
Go deeper on NCT03998449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03998449.